Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 394-68-3 | MDL No. : | MFCD01685514 |
Formula : | C9H6FN | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | RNAAXKYOTPSFGV-UHFFFAOYSA-N |
M.W : | 147.15 | Pubchem ID : | 67856 |
Synonyms : |
|
Num. heavy atoms : | 11 |
Num. arom. heavy atoms : | 10 |
Fraction Csp3 : | 0.0 |
Num. rotatable bonds : | 0 |
Num. H-bond acceptors : | 2.0 |
Num. H-bond donors : | 0.0 |
Molar Refractivity : | 41.7 |
TPSA : | 12.89 Ų |
GI absorption : | High |
BBB permeant : | Yes |
P-gp substrate : | No |
CYP1A2 inhibitor : | Yes |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -5.64 cm/s |
Log Po/w (iLOGP) : | 1.73 |
Log Po/w (XLOGP3) : | 2.19 |
Log Po/w (WLOGP) : | 2.79 |
Log Po/w (MLOGP) : | 2.27 |
Log Po/w (SILICOS-IT) : | 2.91 |
Consensus Log Po/w : | 2.38 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 2.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -2.8 |
Solubility : | 0.231 mg/ml ; 0.00157 mol/l |
Class : | Soluble |
Log S (Ali) : | -2.09 |
Solubility : | 1.18 mg/ml ; 0.00805 mol/l |
Class : | Soluble |
Log S (SILICOS-IT) : | -3.96 |
Solubility : | 0.0162 mg/ml ; 0.00011 mol/l |
Class : | Soluble |
PAINS : | 0.0 alert |
Brenk : | 0.0 alert |
Leadlikeness : | 1.0 |
Synthetic accessibility : | 1.19 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P280-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H302 | Packing Group: | N/A |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
83% | Stage #1: at 130℃; for 1 h; Stage #2: at 130℃; for 18 h; |
85percent sulfuric acid (623 g) was added to a 1 L reaction flask, and o-fluoroaniline (133 g, 1.2 mol) was added dropwise. Warm to 130°C and stir for 2 hours. The reaction temperature was controlled at 130°C, and the mixture was dropped with glycerol (121 g, 1.3 mol) and potassium iodide (3 g). The resulting solution was stirred at 130C for 18 hours after the addition was complete. The reaction solution was cooled to room temperature and slowly added to ice water. After the release, an aqueous solution of sodium hydroxide was added dropwise to adjust the pH to 8-9. Extract with methyl tert-butyl ether to concentrate the separated oil layer. The tert-butyl ether was re-distilled under high vacuum through a packed distillation column to obtain high-purity 8-fluoroquinoline (146 g). The rate is 83percent and the gas chromatogram content is 99.7percent. |
[ 577967-70-5 ]
2-Chloro-6,8-difluoroquinoline
Similarity: 0.84
[ 577967-70-5 ]
2-Chloro-6,8-difluoroquinoline
Similarity: 0.84